Moreover, ROC curve analyses showed that exosomal ADAMTS9‐AS1 had a strong capability of distinguishing CRC patients from healthy controls with AUC value of 0.831, 95% CI: 0.758‐0.889, and the sensitivity and specificity of 91.4% and 71.4%, respectively (Figure 7E). This evidence concerns the gene ADAMTS9 and colorectal carcinoma.